Abstract:Objective Application of nerve growth factor, methylprednisolone, and mild hypothermia in acute spinal cord injury and the effect on oxidative stress.Methods Totally 132 patients with acute spinal cord injury admitted to our hospital from May 2016 to June 2018 were included in the control group and the observation group according to the random number table, 66 cases in each group. The control group was intravenously injected with methylprednisolone sodium succinate for an initial dose of 30 mg/kg, followed by continuous intravenous infusion for 23 hours at a rate of 5.4 mg/kg per hour and mild hypothermia treatment, and the intravenous drip of hibernating mixture was given for 24 h. On the basis of the control group, the observation group received intramuscular injection of mouse nerve growth factor 30 μg/d, continuous administration for 2 months. Recovery indexes of spinal cord function in the two groups were compared, including: ADL score, exercise test score, tactile test score, and acupuncture test score. The changes of oxidative stress levels in serum GSH-Px and SOD levels were observed, as well as the complications in the clinical efficacy of the two groups.Results The ADL, exercise test, tactile test, and acupuncture test of the two groups were higher than those of before treatment, and the elevated level of the observation group was significantly higher than that of the control group (P < 0.05). The level of Oxidative stress markers (GSH-Px and SOD) of both groups were increased after treatment, and the elevated levels in the observation group were significantly higher than control group (P < 0.05). However, there was no significant difference in the incidence of complications between the two groups (P > 0.05).Conclusion Rat nerve growth factor, methylprednisolone combined with mild hypothermia can improve the recovery of nerve function and the quality of life of patients with acute spinal cord injury.